LABEC expands IncellDx HPV OncoTect assay throughout Europe
Labco has been offering HPV OncoTect, a cervical cancer test, on a limited basis since 2010. The HPV OncoTect assay quantifies the overexpression of E6/E7 mRNA, the cancer-causing
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The new office will incorporate the company’s commercialization team handling, while retaining its corporate headquarters, with clinical, manufacturing, regulatory and administration functions, remains in Dublin, Ohio, US. Navidea